Last reviewed · How we verify
NCT04356261: GANDR
Revolutionizing Normative Re-education
Phase 2 trial testing Gamified Personalized Normative Feedback in College Drinking in 1,800 participants. Status unknown.
30 April 2024
Quick facts
| Lead sponsor | Loyola Marymount University |
|---|---|
| Phase | Phase 2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 1,800 |
| Start date | 15 August 2021 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Gamified Personalized Normative Feedback
Conditions studied
- College Drinking — all drugs for College Drinking →
- Underage Drinking — all drugs for Underage Drinking →
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Sponsor
Loyola Marymount University
Who can join
Adults 18 to 20, any sex, with College Drinking or Underage Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Personalized Normative Feedback (PNF), the most widely-used college alcohol intervention approach, suffers from several limitations innovatively remedied in the current proposal through CampusGANDR, a smartphone-based app for college students that delivers alcohol-related PNF within a weekly game centered around testing first-year students' perceptions about the attitudes and behaviors of their peers in a variety of campus-relevant domains. Five pilot studies suggest that CampusGANDR will be significantly more effective at correcting students' normative misperceptions and reducing their alcohol use than standard PNF, especially among heavier-drinking students and those with greater exposure to alcohol on social media, and that these larger effects are driven by the significantly decreased psychological reactance experienced by students when viewing feedback as part of a game about college life rather than as part of an alcohol-focused program. The current project seeks to 1) evaluate the efficacy of CampusGANDR in a large-scale multi-site trial, 2) identify the optimal dosage of alcohol feedback to deliver within CampusGANDR for correcting norms and reducing alcohol use across 12 weeks of gameplay among non-drinking, moderate-drinking, and heavy-drinking students, 3) examine person-level moderators of these effects, and 4) evaluate CampusGANDR engagement and sustainability among students who play voluntarily but are not involved in the randomized controlled trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04356261
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Loyola Marymount University trials
Trials by the same sponsor.
- NCT06861660 — Digitally Prompted Parenting: A Text Message Parent-Based Alcohol Intervention for Incoming College Students · NA · completed
- NCT06576011 — 2 College Truths and 1 Lie · NA · completed
- NCT06191939 — Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma · NA · completed
- NCT04549454 — Parent Feedback Intervention Targeting Student Transitions and Alcohol Related Trajectories (+) Efficacy Study · NA · completed
- NCT03884478 — A Gamified, Social Media Inspired Personalized Normative Feedback Alcohol Intervention for Sexual Minority Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04356261 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Loyola Marymount University
- Last refreshed: 13 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356261.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing